Esophageal Neoplasm Clinical Trials in Taipei
4 recruitingTaipei, Taiwan
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC160 enrolled50 locationsNCT06469944
Recruiting
Phase 1Phase 2
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
Esophageal CancerEsophageal NeoplasmsGastroesophageal Junction+1 more
Merck Sharp & Dohme LLC210 enrolled44 locationsNCT06445972
Recruiting
Not Applicable
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
Esophageal NeoplasmsLung Neoplasm
Taipei Veterans General Hospital, Taiwan200 enrolled2 locationsNCT05875870
Recruiting
Not Applicable
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Head and Neck NeoplasmsEsophageal NeoplasmsNeoplasms+6 more
Taipei Veterans General Hospital, Taiwan20 enrolled1 locationNCT06365866